$TWST
Twist Bioscience Corp

2019 Q4 Form 10-K Financial Statement

#000119312519313115 Filed on December 13, 2019

View on sec.gov

Income Statement

Concept 2019 Q4 2019 Q2 2018 Q3
Revenue $17.16M $13.60M $8.410M
YoY Change 49.36% 107.92% 142.36%
Cost Of Revenue $13.79M $11.39M $9.090M
YoY Change 16.32% 51.86% 33.09%
Gross Profit $3.372M $2.206M -$690.0K
YoY Change -1023.84% -329.31% -79.46%
Gross Profit Margin 19.65% 16.22% -8.2%
Selling, General & Admin $26.41M $21.32M $12.95M
YoY Change 73.05% 89.41% 53.98%
% of Gross Profit 783.07% 966.46%
Research & Development $10.30M $9.007M $6.070M
YoY Change 41.58% 70.98% 25.15%
% of Gross Profit 305.37% 408.3%
Depreciation & Amortization $1.505M $1.580M $1.330M
YoY Change 2.24% -7.06% 6.4%
% of Gross Profit 44.63% 71.62%
Operating Expenses $36.70M $30.33M $19.02M
YoY Change 6.73% 83.53% 43.44%
Operating Profit -$55.83M -$28.12M -$19.71M
YoY Change 143.83% 60.82% 18.59%
Interest Expense $248.0K $318.0K $20.00K
YoY Change -28.74% -5.64% -133.33%
% of Operating Profit
Other Income/Expense, Net -$87.00K -$227.0K -$50.00K
YoY Change 480.0% 1521.43% -76.19%
Pretax Income -$55.60M -$27.86M -$19.73M
YoY Change 146.07% 58.73% 16.81%
Income Tax $37.00K $54.00K $80.00K
% Of Pretax Income
Net Earnings -$55.64M -$27.92M -$19.80M
YoY Change 145.76% 58.4% 16.4%
Net Earnings / Revenue -324.16% -205.26% -235.43%
Basic Earnings Per Share
Diluted Earnings Per Share -$1.687M -$921.8K -$744.1K
COMMON SHARES
Basic Shares Outstanding 33.12M 28.04M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2019 Q4 2019 Q2 2018 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $103.1M $161.8M $80.80M
YoY Change -20.81% 74.92%
Cash & Equivalents $26.03M $68.21M $80.76M
Short-Term Investments $77.10M $93.60M $0.00
Other Short-Term Assets $5.700M $3.600M $3.500M
YoY Change 42.5% 33.33%
Inventory $7.416M $5.496M $6.028M
Prepaid Expenses
Receivables $13.05M $11.70M $5.419M
Other Receivables $1.000M $0.00 $0.00
Total Short-Term Assets $129.3M $182.6M $95.67M
YoY Change -11.85% 75.94%
LONG-TERM ASSETS
Property, Plant & Equipment $21.34M $19.82M $12.33M
YoY Change 56.95% 54.82%
Goodwill $1.138M $1.138M $1.138M
YoY Change 0.0%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $2.237M $2.090M $5.360M
YoY Change 23.18% -50.24%
Total Long-Term Assets $62.99M $24.18M $20.12M
YoY Change 254.07% 27.95%
TOTAL ASSETS
Total Short-Term Assets $129.3M $182.6M $95.67M
Total Long-Term Assets $62.99M $24.18M $20.12M
Total Assets $192.3M $206.8M $115.8M
YoY Change 16.92% 68.55%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $9.106M $7.835M $7.531M
YoY Change 35.41% 74.11%
Accrued Expenses $4.687M $3.713M $2.166M
YoY Change 79.85% -38.12%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $3.333M $3.333M $2.500M
YoY Change 0.0% 96.06%
Total Short-Term Liabilities $57.84M $25.45M $18.54M
YoY Change 204.47% 40.59%
LONG-TERM LIABILITIES
Long-Term Debt $3.669M $5.119M $7.218M
YoY Change -43.78% -98.22%
Other Long-Term Liabilities $144.0K $236.0K $344.0K
YoY Change -56.76% -21.33%
Total Long-Term Liabilities $3.813M $5.355M $7.562M
YoY Change -44.41% -98.14%
TOTAL LIABILITIES
Total Short-Term Liabilities $57.84M $25.45M $18.54M
Total Long-Term Liabilities $3.813M $5.355M $7.562M
Total Liabilities $89.20M $30.80M $26.73M
YoY Change 244.96% -89.91%
SHAREHOLDERS EQUITY
Retained Earnings -$374.2M -$287.3M -$210.9M
YoY Change 60.24%
Common Stock $0.00 $0.00 $0.00
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $103.1M $176.0M -$201.4M
YoY Change
Total Liabilities & Shareholders Equity $192.3M $206.8M $115.8M
YoY Change 16.92% 68.55%

Cashflow Statement

Concept 2019 Q4 2019 Q2 2018 Q3
OPERATING ACTIVITIES
Net Income -$55.64M -$27.92M -$19.80M
YoY Change 145.76% 58.4% 16.4%
Depreciation, Depletion And Amortization $1.505M $1.580M $1.330M
YoY Change 2.24% -7.06% 6.4%
Cash From Operating Activities -$34.91M -$22.08M -$16.69M
YoY Change 61.01% 30.34% 45.64%
INVESTING ACTIVITIES
Capital Expenditures $2.058M -$5.170M -$1.050M
YoY Change 7.08% 720.63% -68.47%
Acquisitions
YoY Change
Other Investing Activities $14.46M -$17.53M $1.450M
YoY Change -122.65% -436.47% -113.04%
Cash From Investing Activities $12.41M -$22.70M $410.0K
YoY Change -118.86% -595.63% -102.84%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $84.30M
YoY Change
Debt Paid & Issued, Net $833.0K
YoY Change
Cash From Financing Activities 2.057M 84.28M 6.580M
YoY Change -97.18% 239.43% 520.75%
NET CHANGE
Cash From Operating Activities -34.91M -22.08M -16.69M
Cash From Investing Activities 12.41M -22.70M 410.0K
Cash From Financing Activities 2.057M 84.28M 6.580M
Net Change In Cash -20.44M 39.50M -9.700M
YoY Change 41.55% 216.76% -60.97%
FREE CASH FLOW
Cash From Operating Activities -$34.91M -$22.08M -$16.69M
Capital Expenditures $2.058M -$5.170M -$1.050M
Free Cash Flow -$36.97M -$16.91M -$15.64M
YoY Change 56.62% 3.68% 92.37%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2019Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
20835000
CY2018Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
12331000
CY2019Q3 us-gaap Goodwill
Goodwill
1138000
CY2018Q3 us-gaap Goodwill
Goodwill
1138000
CY2019Q3 us-gaap Assets
Assets
186994000
CY2018Q3 us-gaap Assets
Assets
115791000
CY2019Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
3799000
CY2018Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
5360000
CY2019Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
12104000
CY2018Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
5419000
CY2019Q3 us-gaap Assets Current
AssetsCurrent
160135000
CY2018Q3 us-gaap Assets Current
AssetsCurrent
95671000
CY2019Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
470425000
CY2018Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
9346000
CY2019Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-318524000
CY2018Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-210855000
CY2019Q3 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
4400000
CY2018Q3 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
7218000
CY2019Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
158000
CY2018Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
344000
CY2019Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
2594000
CY2018Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
3467000
CY2019Q3 us-gaap Short Term Investments
ShortTermInvestments
91372000
CY2018Q3 twst Convertible Preferred Stock Warrant Liability
ConvertiblePreferredStockWarrantLiability
631000
CY2019Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
9760000
CY2018Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
7531000
CY2019Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
5965000
CY2018Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
2166000
CY2019Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2018Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2019Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
10479000
CY2018Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
5401000
CY2018Q3 us-gaap Liabilities
Liabilities
26730000
CY2019Q3 us-gaap Liabilities
Liabilities
34912000
CY2019Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
186994000
CY2018Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
115791000
CY2018Q3 us-gaap Liabilities Current
LiabilitiesCurrent
18537000
CY2019Q3 us-gaap Liabilities Current
LiabilitiesCurrent
30354000
CY2019Q3 us-gaap Long Term Debt Current
LongTermDebtCurrent
3333000
CY2018Q3 us-gaap Long Term Debt Current
LongTermDebtCurrent
2500000
CY2019Q3 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
817000
CY2018Q3 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
939000
CY2018Q3 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
290483000
CY2019Q3 us-gaap Preferred Stock Value
PreferredStockValue
CY2018Q3 us-gaap Preferred Stock Value
PreferredStockValue
CY2019Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
181000
CY2018Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
87000
CY2019Q3 us-gaap Stockholders Equity
StockholdersEquity
152082000
CY2018Q3 us-gaap Stockholders Equity
StockholdersEquity
-201422000
CY2019 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
45000
CY2019Q3 us-gaap Common Stock Value
CommonStockValue
CY2018Q3 us-gaap Common Stock Value
CommonStockValue
CY2019Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.00001
CY2019Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2018Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.00001
CY2018Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
0
CY2019Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2018Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2019Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2018Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2019Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.00001
CY2019Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000
CY2018Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
21210000
CY2019Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
32872675
CY2018Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
3206048
CY2018Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.00001
CY2019Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
32872675
CY2018Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
3206048
CY2019 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
49000
CY2017 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-9000
CY2019 us-gaap Cost Of Revenue
CostOfRevenue
47426000
CY2018 us-gaap Cost Of Revenue
CostOfRevenue
32189000
CY2017 us-gaap Cost Of Revenue
CostOfRevenue
24020000
CY2019 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
35683000
CY2018 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
20347000
CY2017 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
19169000
CY2019 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
80126000
CY2018 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
43450000
CY2017 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
26060000
CY2019 us-gaap Costs And Expenses
CostsAndExpenses
163235000
CY2018 us-gaap Costs And Expenses
CostsAndExpenses
95986000
CY2017 us-gaap Costs And Expenses
CostsAndExpenses
69249000
CY2019 us-gaap Operating Income Loss
OperatingIncomeLoss
-108850000
CY2018 us-gaap Operating Income Loss
OperatingIncomeLoss
-70559000
CY2017 us-gaap Operating Income Loss
OperatingIncomeLoss
-58482000
CY2019 us-gaap Investment Income Interest
InvestmentIncomeInterest
3032000
CY2018 us-gaap Investment Income Interest
InvestmentIncomeInterest
999000
CY2017 us-gaap Investment Income Interest
InvestmentIncomeInterest
412000
CY2019 us-gaap Interest Expense
InterestExpense
1294000
CY2018 us-gaap Interest Expense
InterestExpense
1313000
CY2017 us-gaap Interest Expense
InterestExpense
905000
CY2019 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-265000
CY2018 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-121000
CY2017 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-55000
CY2019 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-107377000
CY2018 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-70994000
CY2017 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-59030000
CY2019 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
292000
CY2018 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
242000
CY2017 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
280000
CY2018 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
54000
CY2017 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
33000
CY2019 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-107575000
CY2018 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-71182000
CY2017 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-59286000
CY2018 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
215000
CY2019 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
153852000
CY2019 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
2264000
CY2019 twst Stock Issued During Period Value Conversion Of Convertible Warrant
StockIssuedDuringPeriodValueConversionOfConvertibleWarrant
631000
CY2016Q3 us-gaap Stockholders Equity
StockholdersEquity
-76611000
CY2017 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
162000
CY2019 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
290462000
CY2018 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2961000
CY2018 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
54000
CY2019 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
11170000
CY2019 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
94000
CY2019 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
6111000
CY2018 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
5727000
CY2019 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
282000
CY2018 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
308000
CY2017Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
31573000
CY2018Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
81537000
CY2019 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-189000
CY2018 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-55000
CY2019 us-gaap Share Based Compensation
ShareBasedCompensation
11170000
CY2019 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-87937000
CY2018 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-66164000
CY2018 us-gaap Share Based Compensation
ShareBasedCompensation
2961000
CY2019 us-gaap Other Noncash Expense
OtherNoncashExpense
233000
CY2018 us-gaap Other Noncash Expense
OtherNoncashExpense
254000
CY2019 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
6685000
CY2018 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
3073000
CY2019 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
1302000
CY2018 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
4202000
CY2019 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-746000
CY2018 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
1760000
CY2019 us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
2064000
CY2018 us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
812000
CY2019 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
3278000
CY2018 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
3759000
CY2019 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
4210000
CY2018 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-114000
CY2019 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
5060000
CY2018 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
1932000
CY2019 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-247000
CY2018 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
50000
CY2019 us-gaap Profit Loss
ProfitLoss
-107669000
CY2019 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
14757000
CY2018 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
3688000
CY2019 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
21000
CY2018 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
17000
CY2019 us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
177574000
CY2018 us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
3523000
CY2019 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-104810000
CY2018 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
27306000
CY2019 us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
2170000
CY2018 us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
331000
CY2019 us-gaap Interest Paid Net
InterestPaidNet
779000
CY2018 us-gaap Interest Paid Net
InterestPaidNet
751000
CY2019 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
291000
CY2018 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
179000
CY2018 us-gaap Liabilities Assumed1
LiabilitiesAssumed1
344000
CY2019 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
158578000
CY2018 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
88822000
CY2018 us-gaap Profit Loss
ProfitLoss
-71236000
CY2017 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
5021000
CY2017 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
95000
CY2016Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
29062000
CY2017 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-507000
CY2017 us-gaap Share Based Compensation
ShareBasedCompensation
1891000
CY2017 us-gaap Other Noncash Expense
OtherNoncashExpense
363000
CY2017 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
1623000
CY2017 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
599000
CY2017 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
324000
CY2017 us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
481000
CY2017 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
560000
CY2017 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
621000
CY2017 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
6594000
CY2017 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
1067000
CY2017 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
650000
CY2017 us-gaap Profit Loss
ProfitLoss
-59310000
CY2017 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
266000
CY2017 us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
40587000
CY2017 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-9990000
CY2017 us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
205000
CY2017 us-gaap Interest Paid Net
InterestPaidNet
702000
CY2017 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
6000
CY2017 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-51301000
CY2017 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
63802000
CY2019Q2 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
84300000
CY2018Q3 us-gaap Deferred Costs
DeferredCosts
3700000
CY2019Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
46735000
CY2018Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
80757000
CY2019Q3 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
579000
CY2018Q3 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
579000
CY2019Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
47398000
CY2017Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
31227000
CY2017Q3 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
202000
CY2019Q3 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
138107000
CY2018Q3 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
80757000
CY2019Q3 us-gaap Inventory Raw Materials
InventoryRawMaterials
4900000
CY2018Q3 us-gaap Inventory Raw Materials
InventoryRawMaterials
2988000
CY2019Q3 us-gaap Inventory Work In Process
InventoryWorkInProcess
1157000
CY2018Q3 us-gaap Inventory Work In Process
InventoryWorkInProcess
2273000
CY2019Q3 us-gaap Inventory Finished Goods
InventoryFinishedGoods
1273000
CY2018Q3 us-gaap Inventory Finished Goods
InventoryFinishedGoods
767000
CY2019Q3 us-gaap Inventory Net
InventoryNet
7330000
CY2018Q3 us-gaap Inventory Net
InventoryNet
6028000
CY2017 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1887000
CY2017 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
24000
CY2019 us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
1249000
CY2019 us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
156208000
CY2018 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
2359000
CY2019 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
2500000
CY2017 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
4173000
CY2019 us-gaap Liabilities Assumed1
LiabilitiesAssumed1
170000
CY2017 us-gaap Liabilities Assumed1
LiabilitiesAssumed1
285000
CY2018 us-gaap Noncash Or Part Noncash Acquisition Payables Assumed1
NoncashOrPartNoncashAcquisitionPayablesAssumed1
1308000
CY2019 twst Conversion Of Convertible Preferred Stock Warrant
ConversionOfConvertiblePreferredStockWarrant
631000
CY2019 us-gaap Conversion Of Stock Amount Converted1
ConversionOfStockAmountConverted1
290462000
CY2017Q3 us-gaap Stockholders Equity
StockholdersEquity
-133358000
CY2019 twst Underwriting Discounts Commissions And Offering Expenses
UnderwritingDiscountsCommissionsAndOfferingExpenses
17210000
CY2018 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-13000
CY2017 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
261000
CY2019 us-gaap Proceeds From Sale Maturity And Collections Of Investments
ProceedsFromSaleMaturityAndCollectionsOfInvestments
87500000
CY2018 us-gaap Proceeds From Sale Maturity And Collections Of Investments
ProceedsFromSaleMaturityAndCollectionsOfInvestments
34500000
CY2017 us-gaap Proceeds From Sale Maturity And Collections Of Investments
ProceedsFromSaleMaturityAndCollectionsOfInvestments
36925000
CY2018 us-gaap Proceeds From Issuance Of Redeemable Convertible Preferred Stock
ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock
90850000
CY2017 us-gaap Proceeds From Issuance Of Redeemable Convertible Preferred Stock
ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock
65596000
CY2019 us-gaap Goodwill Period Increase Decrease
GoodwillPeriodIncreaseDecrease
0
CY2018 us-gaap Goodwill Period Increase Decrease
GoodwillPeriodIncreaseDecrease
0
CY2019 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-34139000
CY2018 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
49964000
CY2017 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
2511000
CY2019Q3 us-gaap Restricted Cash Current
RestrictedCashCurrent
84000
CY2018Q3 us-gaap Restricted Cash Current
RestrictedCashCurrent
201000
CY2017Q3 us-gaap Restricted Cash Current
RestrictedCashCurrent
144000
CY2019Q3 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
1240000
CY2019Q3 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
732000
CY2019Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
508000
CY2018Q3 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
1240000
CY2018Q3 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
528000
CY2018Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
712000
CY2019 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
54385000
CY2018 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
25427000
CY2017 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
10767000
CY2019 us-gaap Net Income Loss
NetIncomeLoss
-107669000
CY2018 us-gaap Net Income Loss
NetIncomeLoss
-71236000
CY2017 us-gaap Net Income Loss
NetIncomeLoss
-59310000
CY2019 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
27461844000
CY2018 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
2792743000
CY2017 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
2422243000
CY2019 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-3.92
CY2018 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-25.51
CY2017 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-24.49
CY2019 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
4177553
CY2018 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
21786253
CY2017 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
17180699
CY2019 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
11170000
CY2018 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
2961000
CY2017 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1891000
CY2018Q4 twst Net Exercise Of Common Stock Warrants Shares
NetExerciseOfCommonStockWarrantsShares
68901
CY2018Q4 twst Common Stock Issued For Cashless Exercise
CommonStockIssuedForCashlessExercise
57122
CY2016Q3 twst Share Based Compensation Arrangement By Share Based Payment Award Options Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAvailableForGrant
470623
CY2016Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1033612
CY2016Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
4.93
CY2016 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P8Y9M21D
CY2017Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
1343301000
CY2017 twst Share Based Compensation Arrangement By Share Based Payment Award Options Available For Grant Additional Shares Authorized In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAvailableForGrantAdditionalSharesAuthorizedInPeriod
1035414
CY2017 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
857082
CY2017 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
8.61
CY2017 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
32586
CY2017 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
5.54
CY2017 twst Share Based Compensation Arrangement By Share Based Payment Award Options Available For Grant Forfeited
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAvailableForGrantForfeited
38384
CY2017 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
38384
CY2017 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
5.54
CY2017Q3 twst Share Based Compensation Arrangement By Share Based Payment Award Options Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAvailableForGrant
687339
CY2017Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1819724
CY2017Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
6.63
CY2017Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue
7147115000
CY2017 twst Share Based Compensation Arrangement By Share Based Payment Award Number Of Options Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfOptionsAvailableForGrant
857082
CY2019Q3 twst Share Based Compensation Arrangement By Share Based Payment Award Options Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAvailableForGrant
1520875
CY2019Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
3550445
CY2018 twst Share Based Compensation Arrangement By Share Based Payment Award Options Available For Grant Additional Shares Authorized In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAvailableForGrantAdditionalSharesAuthorizedInPeriod
905786
CY2019Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
15.99
CY2018 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
62862
CY2019 twst Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant Options Repurchased
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantOptionsRepurchased
442
CY2019 twst Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant Restricted Stock Units Forfeited
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantRestrictedStockUnitsForfeited
26743
CY2018 twst Share Based Compensation Arrangement By Share Based Payment Award Number Of Options Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfOptionsAvailableForGrant
951310
CY2018 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
951310
CY2018 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
10.96
CY2018 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
5.37
CY2018 twst Share Based Compensation Arrangement By Share Based Payment Award Options Available For Grant Forfeited
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAvailableForGrantForfeited
187687
CY2018 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
187687
CY2018 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
7.73
CY2018 twst Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant Options Repurchased
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantOptionsRepurchased
9639
CY2018 twst Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant Restricted Stock Units Forfeited
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantRestrictedStockUnitsForfeited
21146
CY2018Q3 twst Share Based Compensation Arrangement By Share Based Payment Award Options Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAvailableForGrant
860287
CY2018Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
2520485
CY2018Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
8.22
CY2018Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue
11482909000
CY2019 twst Share Based Compensation Arrangement By Share Based Payment Award Options Available For Grant Additional Shares Authorized In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAvailableForGrantAdditionalSharesAuthorizedInPeriod
2494700
CY2019 twst Share Based Compensation Arrangement By Share Based Payment Award Number Of Options Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfOptionsAvailableForGrant
1685625
CY2019 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
1685625
CY2019 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
25.53
CY2019 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
331205
CY2019 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
6.67
CY2019 twst Share Based Compensation Arrangement By Share Based Payment Award Options Available For Grant Forfeited
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAvailableForGrantForfeited
324460
CY2019 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
324460
CY2019 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
14.75
CY2019 twst Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant Restricted Stock Units Granted In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantRestrictedStockUnitsGrantedInPeriod
500132
CY2019Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue
31997934000
CY2019 us-gaap Related Party Transaction Purchases From Related Party
RelatedPartyTransactionPurchasesFromRelatedParty
3200000
CY2018 us-gaap Related Party Transaction Purchases From Related Party
RelatedPartyTransactionPurchasesFromRelatedParty
2300000
CY2017 us-gaap Related Party Transaction Purchases From Related Party
RelatedPartyTransactionPurchasesFromRelatedParty
2000000
CY2019 us-gaap Related Party Transaction Description Of Transaction
RelatedPartyTransactionDescriptionOfTransaction
During the year ended September 30, 2019, the Company purchased raw materials from a related party investor in the amount of $3.2 million. Payable balances and cash receipts and receivable balances with the related party were immaterial as of September 30, 2019.
CY2018 us-gaap Related Party Transaction Description Of Transaction
RelatedPartyTransactionDescriptionOfTransaction
During the year ended September 30, 2018, the Company purchased raw materials from a related party investor in the amount of $2.3 million. Payable balances and cash receipts and receivable balances with the related party were immaterial as of September 30, 2018.
CY2019 us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
2700000
CY2017 us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
2174000
CY2019 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
30000
CY2017 us-gaap Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
486000
CY2019Q3 twst Net Exercise Of Common Stock Warrants Shares
NetExerciseOfCommonStockWarrantsShares
32064
CY2019Q3 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
6.24
CY2019Q3 twst Common Stock Issued For Cashless Exercise
CommonStockIssuedForCashlessExercise
25422
CY2017 us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
486000
CY2018 twst Treasury Stock Repurchased During Period Value
TreasuryStockRepurchasedDuringPeriodValue
-58000
CY2019 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
2700000
CY2017 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P9Y1M20D
CY2018 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P8Y4M17D
CY2019 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P8Y3M
CY2019Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
3550445
CY2019Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
15.99
CY2019 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
P8Y3M
CY2019Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
31997934000
CY2019Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
1243634
CY2019Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
7.77
CY2019 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P7Y3D
CY2019Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
20125913000
CY2019 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y4M27D
CY2018 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y3M
CY2017 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y3M
CY2019 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.602
CY2018 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.663
CY2017 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.655
CY2019 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0272
CY2018 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0265
CY2017 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0202
CY2019 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.0
CY2018 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.0
CY2017 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.0
CY2019Q3 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
CY2019Q3 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
73341000
CY2018Q3 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
49801000
CY2019Q3 us-gaap Deferred Tax Assets Tax Credit Carryforwards Research
DeferredTaxAssetsTaxCreditCarryforwardsResearch
6831000
CY2018Q3 us-gaap Deferred Tax Assets Tax Credit Carryforwards Research
DeferredTaxAssetsTaxCreditCarryforwardsResearch
4621000
CY2019Q3 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
4553000
CY2018Q3 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
1919000
CY2019Q3 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
84725000
CY2018Q3 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
56341000
CY2019Q3 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
84598000
CY2018Q3 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
56158000
CY2019Q3 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
127000
CY2018Q3 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
183000
CY2019Q3 us-gaap Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
1000
CY2018Q3 us-gaap Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
1000
CY2019Q3 us-gaap Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets
DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets
126000
CY2018Q3 us-gaap Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets
DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets
182000
CY2019Q3 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
127000
CY2018Q3 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
183000
CY2018Q3 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
CY2019 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2018 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.24
CY2017 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.35
CY2019 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.22
CY2018 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
0.04
CY2017 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.35
CY2019 us-gaap Effective Income Tax Rate Reconciliation Tax Credits Research
EffectiveIncomeTaxRateReconciliationTaxCreditsResearch
0.01
CY2018 us-gaap Effective Income Tax Rate Reconciliation Tax Credits Research
EffectiveIncomeTaxRateReconciliationTaxCreditsResearch
0.01
CY2017 us-gaap Effective Income Tax Rate Reconciliation Tax Credits Research
EffectiveIncomeTaxRateReconciliationTaxCreditsResearch
0.01
CY2019 us-gaap Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate
EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate
CY2018 us-gaap Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate
EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate
-0.28
CY2017 us-gaap Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate
EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate
CY2019 us-gaap Effective Income Tax Rate Reconciliation Deductions Other
EffectiveIncomeTaxRateReconciliationDeductionsOther
CY2018 us-gaap Effective Income Tax Rate Reconciliation Deductions Other
EffectiveIncomeTaxRateReconciliationDeductionsOther
-0.01
CY2017 us-gaap Effective Income Tax Rate Reconciliation Deductions Other
EffectiveIncomeTaxRateReconciliationDeductionsOther
-0.01
CY2019 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
CY2018 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
CY2017 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
CY2016Q3 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
822000
CY2017 us-gaap Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
562000
CY2017 us-gaap Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
241000
CY2017Q3 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
1625000
CY2018 us-gaap Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
624000
CY2018Q3 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
2249000
CY2019Q3 us-gaap Operating Leases Future Minimum Payments Due In Three Years
OperatingLeasesFutureMinimumPaymentsDueInThreeYears
5979000
CY2019Q3 us-gaap Operating Leases Future Minimum Payments Due In Four Years
OperatingLeasesFutureMinimumPaymentsDueInFourYears
6064000
CY2019Q3 us-gaap Operating Leases Future Minimum Payments Due In Five Years
OperatingLeasesFutureMinimumPaymentsDueInFiveYears
6029000
CY2019Q3 us-gaap Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
40719000
CY2019 us-gaap Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
1042000
CY2019Q3 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
3291000
CY2019 us-gaap Operating Loss Carryforwards Limitations On Use
OperatingLossCarryforwardsLimitationsOnUse
For net operating losses generated in the years beginning after December 31, 2017, utilization is limited to 80% of taxable income with an unlimited carryforward period.
CY2019Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
203000
CY2019Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
203000
CY2019Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
102000
CY2019Q3 us-gaap Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
5909000
CY2019Q3 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
11085000
CY2018Q3 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
5439000
CY2019Q3 us-gaap Other Receivables Gross Current
OtherReceivablesGrossCurrent
1313000
CY2018Q3 us-gaap Other Receivables Gross Current
OtherReceivablesGrossCurrent
75000
CY2019Q3 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
294000
CY2018Q3 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
95000
CY2017 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Restricted Stock Units Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition
4000
CY2019 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2019 dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
CY2019 dei Security12b Title
Security12bTitle
Common Stock
CY2019 dei Trading Symbol
TradingSymbol
TWST
CY2019 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2019Q3 twst Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested And Expected To Vest Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndExpectedToVestWeightedAverageGrantDateFairValue
26.16
CY2019 twst Tax Credit
TaxCredit
2033
CY2019Q3 twst Net Exercise Of Common Stock Warrants Shares
NetExerciseOfCommonStockWarrantsShares
16221
CY2019Q3 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
7.84
CY2019Q3 twst Common Stock Issued For Cashless Exercise
CommonStockIssuedForCashlessExercise
12019
CY2019Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
33118096
CY2018Q3 us-gaap Cash Cash Equivalents And Short Term Investments
CashCashEquivalentsAndShortTermInvestments
80757000
CY2019 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
4900000
CY2018 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
2500000
CY2017 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
2200000
CY2019Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
43828000
CY2018Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
29583000
CY2019Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
22993000
CY2018Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
17252000
CY2019Q3 twst Cash And Cash Equivalents At Amortized Cost
CashAndCashEquivalentsAtAmortizedCost
46735000
CY2019Q3 us-gaap Available For Sale Securities Amortized Cost
AvailableForSaleSecuritiesAmortizedCost
91323000
CY2019 us-gaap Available For Sale Securities Gross Unrealized Gains
AvailableForSaleSecuritiesGrossUnrealizedGains
49000
CY2019Q3 twst Cash And Cash Equivalents And Short Term Invesmtnets Amortized Cost
CashAndCashEquivalentsAndShortTermInvesmtnetsAmortizedCost
138058000
CY2019 twst Availableforsale Securities Gross Unrealized Gain Loss
AvailableforsaleSecuritiesGrossUnrealizedGainLoss
49000
CY2019Q3 us-gaap Cash Cash Equivalents And Short Term Investments
CashCashEquivalentsAndShortTermInvestments
138107000
CY2018Q3 twst Cash And Cash Equivalents At Amortized Cost
CashAndCashEquivalentsAtAmortizedCost
80757000
CY2018Q3 twst Cash And Cash Equivalents And Short Term Invesmtnets Amortized Cost
CashAndCashEquivalentsAndShortTermInvesmtnetsAmortizedCost
80757000
CY2019Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Next Twelve Months
LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
3333000
CY2019Q3 twst Long Term Debt Maturities Interest Payable In Next Twelve Months
LongTermDebtMaturitiesInterestPayableInNextTwelveMonths
-486000
CY2019Q3 twst Long Term Debt Maturities Repayment Principal And Interest In Next Twelve Months
LongTermDebtMaturitiesRepaymentPrincipalAndInterestInNextTwelveMonths
3819000
CY2019Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
3333000
CY2019Q3 twst Long Term Debt Maturities Interest Payable In Year Two
LongTermDebtMaturitiesInterestPayableInYearTwo
-214000
CY2019Q3 twst Long Term Debt Maturities Repayment Principal And Interest In Year Two
LongTermDebtMaturitiesRepaymentPrincipalAndInterestInYearTwo
3547000
CY2019Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
834000
CY2019Q3 twst Long Term Debt Maturities Interest Payable In Year Three
LongTermDebtMaturitiesInterestPayableInYearThree
-11000
CY2019Q3 twst Long Term Debt Maturities Repayment Principal And Interest In Year Three
LongTermDebtMaturitiesRepaymentPrincipalAndInterestInYearThree
845000
CY2019Q3 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
7500000
CY2019Q3 twst Interest Payable On Long Term Debt
InterestPayableOnLongTermDebt
-711000
CY2019Q3 twst Long Term Debt Maturities Repayment Principal And Interesttotal
LongTermDebtMaturitiesRepaymentPrincipalAndInteresttotal
8211000
CY2019Q3 us-gaap Long Term Debt
LongTermDebt
7500000
CY2019Q3 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
269000
CY2019Q3 twst Accretion Of Final Payment Fee
AccretionOfFinalPaymentFee
502000
CY2019Q3 twst Long Term Debt Including Interest And Fee Payable
LongTermDebtIncludingInterestAndFeePayable
7733000
CY2019 us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
0
CY2018 us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
0
CY2016 us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
0
CY2019Q3 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
0
CY2018Q3 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
0
CY2019Q3 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
0
CY2018Q3 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
0
CY2019 us-gaap Advertising Expense
AdvertisingExpense
1300000
CY2018 us-gaap Advertising Expense
AdvertisingExpense
900000
CY2017 us-gaap Advertising Expense
AdvertisingExpense
100000
CY2017 twst Contract Payments Research And Development Received
ContractPaymentsResearchAndDevelopmentReceived
0
CY2019 twst Common Stock Warrants Issued During The Period
CommonStockWarrantsIssuedDuringThePeriod
0
CY2018 twst Common Stock Warrants Issued During The Period
CommonStockWarrantsIssuedDuringThePeriod
0
CY2019 dei Entity Registrant Name
EntityRegistrantName
Twist Bioscience Corp
CY2019 twst Credit Period Granted To Customers
CreditPeriodGrantedToCustomers
P30D
CY2019 us-gaap Depreciation And Amortization
DepreciationAndAmortization
6100000
CY2018 us-gaap Depreciation And Amortization
DepreciationAndAmortization
5500000
CY2017 us-gaap Depreciation And Amortization
DepreciationAndAmortization
4800000
CY2019Q3 us-gaap Capitalized Computer Software Net
CapitalizedComputerSoftwareNet
2300000
CY2018Q3 us-gaap Capitalized Computer Software Net
CapitalizedComputerSoftwareNet
1900000
CY2019 dei Entity Central Index Key
EntityCentralIndexKey
0001581280
CY2019 dei Document Type
DocumentType
10-K
CY2019 dei Amendment Flag
AmendmentFlag
false
CY2019 dei Document Period End Date
DocumentPeriodEndDate
2019-09-30
CY2019 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2019
CY2019 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2019 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--09-30
CY2019 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2019 dei Entity Shell Company
EntityShellCompany
false
CY2019 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2019 dei Entity Small Business
EntitySmallBusiness
true
CY2019 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
CY2019 dei Entity Ex Transition Period
EntityExTransitionPeriod
true
CY2019 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2019 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2019 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div style="font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt; background: none;"><div style="background: none; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style:italic;display:inline;;font-style:italic;display:inline;">Concentration of credit risk </div></div></div></div><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; background: none;"><div style="background: none; letter-spacing: 0px; top: 0px;;display:inline;">Financial instruments that potentially subject the Company to a concentration of credit risk consist of cash and cash equivalents, short-term investments and accounts receivable. Substantially all of the Company&#8217;s cash is held by one financial institution that management believes is of high credit quality. Such deposits may, at times, exceed federally insured limits. The Company&#8217;s investment policy addresses the level of credit exposure by establishing a minimum allowable credit rating and by limiting the concentration in any one investment. </div></div><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt; background: none;"><div style="background: none; letter-spacing: 0px; top: 0px;;display:inline;">The Company&#8217;s accounts receivable is derived from customers located principally in the United States and Europe. The Company maintains credit insurance for certain of its customer balances, performs ongoing credit evaluations of its customers, and maintains allowances for potential credit losses on customers&#8217; accounts when deemed necessary. The Company does not typically require collateral from its customers. Credit losses historically have not been material. The Company continuously monitors customer payments and maintains an allowance for doubtful accounts based on its assessment of various factors including historical experience, age of the receivable balances, and other current economic conditions or other factors that may affect customers&#8217; ability to pay. </div></div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>
CY2019Q1 dei Entity Public Float
EntityPublicFloat
402000000
CY2019 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2019 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Award Vesting Rights Percentage
SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage
0.25
CY2019Q3 twst Sharebased Compensation Arrangement By Sharebased Payment Award Right Of Repurchase
SharebasedCompensationArrangementBySharebasedPaymentAwardRightOfRepurchase
38157
CY2019 us-gaap Tax Credit Carryforward Limitations On Use
TaxCreditCarryforwardLimitationsOnUse
For net operating losses generated in the years beginning after December&#160;31, 2017, utilization is limited to 80% of taxable income with an immaterial provision for income taxesunlimited carryforward period. The Company recognized the effect of the tax law changes in the period of enactment, which required a remeasurement of its U.S. deferred tax assets and liabilities
CY2019Q3 us-gaap Operating Leases Future Minimum Payments Due Thereafter
OperatingLeasesFutureMinimumPaymentsDueThereafter
10067000
CY2019Q3 us-gaap Operating Leases Future Minimum Payments Due Current
OperatingLeasesFutureMinimumPaymentsDueCurrent
6671000
CY2019 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
15.06
CY2018 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
7.08
CY2017 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
6.63
CY2019Q3 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
24800000
CY2019 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P3Y4M24D

Files In Submission

Name View Source Status
0001193125-19-313115-index-headers.html Edgar Link pending
0001193125-19-313115-index.html Edgar Link pending
0001193125-19-313115.txt Edgar Link pending
0001193125-19-313115-xbrl.zip Edgar Link pending
d65251d10k.htm Edgar Link pending
d65251dex211.htm Edgar Link pending
d65251dex231.htm Edgar Link pending
d65251dex311.htm Edgar Link pending
d65251dex312.htm Edgar Link pending
d65251dex321.htm Edgar Link pending
d65251dex322.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
g65251g36n93.jpg Edgar Link pending
g65251g88y92.jpg Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
twst-20190930.xml Edgar Link completed
twst-20190930.xsd Edgar Link pending
twst-20190930_cal.xml Edgar Link unprocessable
twst-20190930_def.xml Edgar Link unprocessable
twst-20190930_lab.xml Edgar Link unprocessable
twst-20190930_pre.xml Edgar Link unprocessable